BioLineRx Ltd. (BLRX) Social Stream
BIOLINERX LTD (BLRX) Price Targets From Analysts
Use the tables below to see what analysts covering BIOLINERX LTD think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-01-18 | 2 | $19 | $10 | $14.5 | $1.98 | 632.32% |
2022-01-31 | 1 | $19 | $7.25 | $12.083 | $1.98 | 510.25% |
2022-05-12 | 2 | $19 | $7.25 | $12.083 | $1.98 | 510.25% |
2022-08-18 | 2 | $19 | $6 | $10.75 | $1.98 | 442.93% |
2022-09-28 | 2 | $19 | $4 | $10.083 | $1.98 | 409.24% |
2023-06-07 | 2 | $19 | $4 | $9.666 | $1.98 | 388.18% |
2023-09-05 | 1 | $19 | $6 | $12.5 | $1.98 | 531.31% |
2023-09-14 | 1 | $19 | $7 | $13 | $1.98 | 556.57% |
2023-09-15 | 1 | $21 | $7 | $14 | $1.98 | 607.07% |
Price Target Last Issued September 14, 2023
The Trend in the Analyst Price Target
Over the past 13 months, BLRX's average price target has gone up $3.25.
Over the past 50 weeks, BLRX's average upside potential has been 775.97%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-11-15 | 2 | 19 | 4 | 9.666 | 0.68 | 1321.47% |
2023-06-07 | 2 | 19 | 4 | 9.666 | 1.62 | 496.67% |
2023-06-07 | 2 | 19 | 6 | 12.500 | 1.62 | 671.6% |
2023-08-31 | 1 | 19 | 6 | 12.500 | 1.75 | 614.29% |
2023-09-05 | 1 | 19 | 6 | 12.500 | 2.45 | 410.2% |
BLRX Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
BLRX's average broker recommendation rating improved by 0 over the prior 52 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BLRX as an investment opportunity.
- BLRX has a higher number of analysts covering the stock than 18.42% of all US stocks.
- In terms of how BIOLINERX LTD fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 930.1% of that group.
- BIOLINERX LTD's variance in analysts' estimates is lower than -781.41% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, BIOLINERX LTD's average analyst price target is greater than 217.91% of them.
In the Pharmaceutical Products industry, GLMD, EDSA, and BLPH are the three stocks most similar to BIOLINERX LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BLRX a Buy, Hold or Sell? See the POWR Ratings now!